Inserra, Antonio http://orcid.org/0000-0002-7261-5659
Piot, Alexandre http://orcid.org/0000-0002-4019-5127
De Gregorio, Danilo http://orcid.org/0000-0002-8623-0661
Gobbi, Gabriella http://orcid.org/0000-0003-4124-9825
Funding for this research was provided by:
Canadian Institutes of Health Research
Fonds de Recherche Santé du Québec
Réseau Québécois sur le Suicide, les Troubles de l'Humeur et Troubles Associés
Article History
Accepted: 19 April 2023
First Online: 21 August 2023
Declarations
:
: This work was supported by grants from the CIHR (Canadian Institutes of Health Research), FRQS (Fonds de Recherche Santé du Québec), and RQSHA (Réseau Québécois sur le Suicide, les Troubles de l’Humeur et Troubles Associés). G.G. holds the Canada Research Chair in Therapeutics for Mental Health. A.I. received the CIHR post-doctoral fellowship.
: D.D.G. is a consultant at Diamond Therapeutics Inc., Toronto, ON, Canada. D.D.G. and G.G. are inventors of a pending patent on the method-of-use of LSD.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Conceptualization: IA, GG; writing—original draft preparation: IA, AP, DDG, GG; writing—review and editing: IA, AP, DDG, GG; supervision: GG.